ARA-290 vs Normoftal
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Cibinetide, ARA 290
An 11-amino acid peptide derived from erythropoietin (EPO) that activates the innate repair receptor. Unlike EPO, it has no erythropoietic activity but provides cytoprotective, anti-inflammatory, and tissue-protective effects.
Also: Eye Peptide Bioregulator, Retina Peptide
A synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. Developed to normalize retinal function and support eye health. Clinical studies in Russia report improved visual function in 95% of patients with various retinal pathologies.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
Detailed Comparison
| Attribute | ARA-290 | Normoftal |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | ARA-290 selectively activates the innate repair receptor (IRR), a heterodimer of EPOR and CD131 (β common receptor). This receptor is expressed on damaged and inflamed tissues. Activation triggers anti-apoptotic, anti-inflammatory, and tissue-protective pathways without stimulating red blood cell production. | Normoftal normalizes eye function by reducing peptide deficiency and restoring protein synthesis inside retinal cells. Contains peptide AKS-G (lysine, glutamic acid). May have neuroprotective effects on retinal neurons by modulating gene expression and protein synthesis, helping preserve the integrity and function of retinal nerve cells critical for transmitting visual information to the brain. |
| Common Dosing | 4 mg daily Once daily | 2 capsules 1-2x daily 1-2x daily, before meals |
| Administration | Subcutaneous injection | Oral capsules, before meals |
| Typical Duration | 28-day courses in trials | 30-day courses, repeat after 2-6 months |
| Best Time to Take | Consistent daily timing | Morning and evening, before meals |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Phase II/III clinical trials for diabetic neuropathy show improvement in corneal nerve fiber density and small fiber function. Orphan Drug Designation granted in both US and EU for sarcoidosis treatment. Studies demonstrate efficacy in small fiber neuropathy, neuropathic pain, and sarcoidosis-related symptoms. Being developed by Araim Pharmaceuticals. | From 1995 to 2010, at the St. Petersburg Institute of Bioregulation and Gerontology, 1500 patients with retinal pathology were treated: 40.3% with macular degeneration, 30.3% with diabetic retinopathy, 23.0% with retinitis pigmentosa. Improved visual functions were reported in 95% of patients. Research suggests it may aid treatment of glaucoma, diabetic retinopathy, and age-related macular degeneration. |
Frequently Asked Questions: ARA-290 vs Normoftal
What is the difference between ARA-290 and Normoftal?
ARA-290 is a cognitive peptide that an 11-amino acid peptide derived from erythropoietin (epo) that activates the innate repair receptor. unlike epo, it has no erythropoietic activity but provides cytoprotective, anti-inflammatory, and tissue-protective effects. Normoftal is a cognitive peptide that a synthesized khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. developed to normalize retinal function and support eye health. clinical studies in russia report improved visual function in 95% of patients with various retinal pathologies. The main differences lie in their mechanisms of action and clinical applications.
Which is better, ARA-290 or Normoftal?
Neither is universally "better" - the choice depends on your specific goals. ARA-290 is typically used for cognitive purposes, while Normoftal is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can ARA-290 and Normoftal be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using ARA-290 and Normoftal together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of ARA-290 and Normoftal is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.